Effects of mixed tocopherols added to milk replacer and calf starter on intake, growth, and indices of stress.

Vitamin E comprises 8 fat-soluble isoforms: α-, ß-, γ-, and δ-tocopherol and α-, ß-, γ-, and δ-tocotrienol. Yet the body preferentially uses α-tocopherol, and only α-tocopherol supplementation can reverse vitamin E deficiency symptoms. However, other isoforms influence many biological functions in the body, including inflammation and stress. Therefore, the study objective was to determine metabolic and performance responses in young calves fed diets containing a constant amount of α-tocopherol and increasing amounts of soybean oil-derived mixed γ- and δ-tocopherols. Holstein calves [n = 48; 2-3 d of age; 40.2 kg of initial body weight (BW), standard error = 0.54] were assigned to receive approximately 0, 5, 10, or 15 mg/kg of BW daily (treatments T0, T1, T2, and T3, respectively) of mixed tocopherols (TMIX) provided in milk replacer (MR) and calf starter. The TMIX liquid contained 86% γδ-tocopherols and 9% α-tocopherol. Milk replacers were formulated to contain approximately 0, 400, 800, or 1,200 mg of TMIX/kg for treatments T0, T1, T2, and T3, respectively. Calf starters were formulated to contain approximately 0, 250, 500, or 750 mg of TMIX/kg for treatments T0, T1, T2, and T3, respectively. Mean consumption of γδ-tocopherols was 0.0, 6.5, 14.3, and 20.5 mg/kg of BW, respectively. Milk replacer contained 24% crude protein (CP) and 20% fat on a dry matter (DM) basis. Calf starters were pelleted and offered for ad libitum consumption from 0 to 56 d. Starters contained 18 to 20% CP and 9 to 12% starch in the DM. On d 28, 4 calves per treatment were randomly selected for slaughter, and necropsy was performed. Samples of liver, duodenum, ileum, and trapezius muscle were collected and stored before analysis for α-, ß-, γ-, and δ-tocopherols and δ-tocotrienol. Data were analyzed using a completely randomized design using mixed model ANOVA with orthogonal polynomials to determine linear and quadratic effects of TMIX. Repeated-measures analyses were performed for data collected over time. Increasing dietary TMIX increased or tended to increase change in hip width at 28 and 56 d, respectively, and improved average daily BW gain and gain-to-feed ratio at 56 d. Increasing TMIX reduced plasma xanthine oxidase at 0 h and tended to reduce concentrations at 24 h following vaccination with 2 commercial vaccines on d 28; however, we detected no effect of TMIX following vaccination on d 56. Concentration of α-tocopherol in skeletal muscle declined quadratically with increasing TMIX, whereas ileal and liver γ-tocopherol increased linearly with increasing TMIX. The number of mucin-2 cells in the ileum increased more than 2-fold in calves fed T3. Addition of mixed tocopherols to diets of young dairy calves improved animal growth and altered indices of antioxidant metabolism.

Effect of starter form, starch concentration, and amount of forage fed on Holstein calf growth from 2 to 4 months of age.

Young, weaned calves are commonly offered ad libitum forage with limited amounts of starter, in contrast to the suggested amount of approximately 5% forage in the diet due to the limited capacity of the rumen, as well as limited ability to digest high fiber feeds. The objective of this research was to compare 2 types of starters (low starch, pelleted vs. high starch, textured), both fed either ad libitum with 5% chopped hay, or fed at restricted rates with ad libitum long grass hay to calves between 2 and 4 mo of age. In trial 1, 48 calves were housed in group pens (68.4 ± 3.37 kg of initial body weight ± standard deviation; 3 pens of 4 calves/pen) and randomly assigned to 1 of 4 diets: (1) low starch pelleted starter (8% starch) blended with 5% chopped hay fed free choice; (2) high starch textured starter (45% starch) blended with 5% chopped hay fed free choice; (3) low starch pelleted starter (8% starch) fed at a rate up to 2.3 kg of dry matter (DM)/d, with free-choice long grass hay; or (4) high starch textured starter (45% starch) fed at a rate up to 2.3 kg of DM/d, with free-choice long grass hay. Trial 1 was analyzed as a completely randomized design using a 2 × 2 arrangement of treatments. Repeated measures were used as appropriate. Pen was the experimental unit. In trial 2, 48 calves (76.4 ± 1.55 kg of initial body weight; 6 pens of 4 calves/pen) were randomly assigned to 1 of 2 diets: (1) ad libitum access to a blend of 95% high starch textured starter (42% starch) and 5% chopped grass hay; or (2) high starch textured starter fed up to 2.7 kg of DM/d with free-choice long grass hay. Trial 2 was analyzed as for trial 1, without factorial arrangement. Trials were 56 d long. In trial 1, feed efficiency, average daily gain (ADG), and change in hip width were greater for calves fed high versus low starch diet. Final hip width, ADG, DM intake, and change in hip width were greater for calves fed limited chopped versus free-choice long hay diets. In trial 2, intake, feed efficiency, and all growth measurements were greater in calves fed the ad libitum mixed diet compared with those limit-fed starter up to 2.7 kg as fed with ad libitum hay. Ad libitum hay intake was highly variable among pens and differed up to 2.5-fold by the last week of the trials. In both trials, restricted feeding of starter with ad libitum long grass hay reduced total DM intake by 13 to 17%, ADG by 20%, and hip width change by 10 to 23% compared with a blend of 95% starter and 5% chopped grass hay fed ad libitum.

Effects of colostrum and milk replacer feeding rates on intake, growth, and digestibility in calves.

Newborn Holstein male calves (n = 50) born on a single dairy farm were assigned randomly at birth to receive 3 feedings of 1.8 L of pooled maternal colostrum (MC) at 1, 6, and 12 h of age or 1 feeding of 500 g of a colostrum replacer reconstituted to 1.8 L at 1 h of age, followed by 2 feedings of 227 g of a commercial milk replacer (MR) reconstituted to 1.8 L at 6 and 12 h of age (CR). All feedings were administered by esophageal feeder. At 2 to 3 d of age, calves were transported to the experimental facility and assigned within colostrum group to receive 0.66 kg/d dry matter (DM) of MR to 39 d, and then 0.33 kg/d to 42 d (MRM) or 0.77 kg/d of MR DM to d 13, 1.03 kg/d for 22 d, and 0.51 kg/d for 7 d (MRH). The MR contained 25.8% crude protein and 17.6% crude fat (DM basis) and was based on whey proteins and lard as the primary fat source. Calf starter (21.7% crude protein, 15.7% neutral detergent fiber, 37.4% starch, DM basis) and water were available for ad libitum consumption throughout the 56-d study. Serum IgG and total protein were measured at 2 to 3 d of age. Intakes of MR and calf starter were monitored daily. Calf health and fecal scores were also monitored daily. Body weight was measured weekly, and hip width and body condition score were monitored every 2 wk. Digestion of DM, organic matter, crude protein, and ether extract were determined at 1 and 3 wk from 5 calves randomly selected within treatment and using chromic oxide as a digestibility marker added to the MR. Calves fed CR had lower serum IgG and total protein than calves fed MC. Also, calves fed CR grew more slowly, consumed less calf starter, and were less efficient to 56 d than calves fed MC. The number of days calves were treated with veterinary medications was higher when calves were fed CR. Calves fed MC-MRH gained more BW than other calves from 3 to 8 wk of age. Calves fed CR-MRH consumed less calf starter than other calves during wk 7 and 8. Digestion of nutrients at 1 and 3 wk of the study was unaffected by type of colostrum or level of MR fed and did not change from 1 to 3 wk. Over the first 2 mo of life, the calves fed MRH consumed less calf starter than calves fed MRM, but average daily gain or hip width change did not differ. One feeding of CR followed by 2 feedings of MR in the first 24 h likely reduced absorption of IgG from CR and contributed to differences in health and growth. Differences in animal performance observed in this study were unrelated to MR digestibility.

Effects of fatty acids and calf starter form on intake, growth, digestion, and selected blood metabolites in male calves from 0 to 4 months of age.

The objective of this research was to determine if form of calf starter (CS) and addition of a fatty acid blend (FA) influenced intake, growth, digestion, and indices of immune status and stress in calves from 0 to 4 mo of age. Male Holstein calves [n = 48; 41.9 kg of body weight (BW), standard error = 0.7; 2 to 3 d of age] were assigned to receive reconstituted whole milk powder [0.66 kg of dry matter (DM)/d to 39 d, then 0.33 kg of DM/d to weaning at 42 d] without or with added FA. Calf starters were textured (pellet, whole oats, whole corn) or pelleted and were offered for ad libitum consumption from 0 to 56 d, then blended with 5% chopped grass hay and fed from d 57 to 112. Starters contained 20% crude protein (CP) and 38 to 40% starch in the DM. From d 0 to 56, calves were housed individually. From d 57 to 112, calves were grouped into pens by treatment (n = 4/pen). Form of CS during the initial 56 d had no effect on intake or growth, though days with fluid feces (fecal score ≥2.5) were greater when calves were fed textured CS. Feeding FA during the initial 56-d increased average daily BW gain, gain-to-feed ratio, and change in hip width, and reduced the number of days calves were treated with antibiotics. During d 57 to 112, CS form had no effects on any performance measure. Adding FA to CS increased average daily BW gain and hip width change, and tended to improve efficiency of BW gain. Total-tract digestibility was estimated at 4, 6, and 8 wk with 5 calves per treatment, and at 10, 13, and 16 wk of age using pen (n = 3 per treatment) as the experimental unit. Feeding FA increased or tended to increase total-tract digestion of DM, organic matter, starch, neutral detergent fiber (NDF), acid detergent fiber (ADF), CP, and fat at one or more measurement periods. Calves fed a textured CS increased or tended to increase digestion of DM, organic matter, starch, sugar, NDF, ADF, and CP during wk 6 and 8. However, during the second 56-d phase, feeding textured CS reduced or tended to reduce digestion of DM, organic matter, starch, NDF, ADF, and fat during wk 13 and 16. Inclusion of FA in milk increased serum bactericidal activity before weaning. Serum haptoglobin concentration increased 3 d postweaning when calves were fed textured CS. Feeding FA improved animal health, digestion, and performance. Form of CS had few effects on animal performance.

No effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study.

Vitamin D plays a role in muscle function through genomic and non-genomic processes. The objective of this RCT was to determine the effect of monthly supplemental vitamin D3 onmuscle function in 70+ years old adults. Participants (n = 379) were randomized to receive, 12,000 IU, 24,000 IU or 48,000 IU of vitamin D3 monthly for 12 months. Standardized Hand Grip Strength (GS) and Timed-Up and Go (TUG) were measured before and after vitamin D3 supplementation. Fasting total plasma 25 hydroxyvitamin D (25OHD) and Parathyroid Hormone (PTH) concentrations were measured by Liquid Chromatography Tandem Mass Spectrometry (LC-MSMS) and immunoassay, respectively. Baseline plasma 25OHD concentrations were 41.3 (SD 19.9), 39.5 (SD 20.6), 38.9 (SD 19.7) nmol/L; GS values were 28.5 (SD 13.4), 28.8 (SD 13.0) and 28.1 (SD 12.1) kg and TUG test values were 10.8 (SD 2.5), 11.6 (SD 2.9) and 11.9 (SD 3.6) s for the 12,000 IU, 24,000 IU and 48,000 IU dose groups, respectively. Baseline plasma 25OHD concentration < 25 nmol/L was associated with lower GS (P = 0.003). Post-interventional plasma 25OHD concentrations increased to 55.9 (SD 15.6), 64.6 (SD15.3) and 79.0 (SD 15.1) nmol/L in the 12,000 IU, 24,000 IU and 48,000 IU dose groups, respectively and there was a significant dose-related response in post-interventional plasma 25OHD concentration (p<0.0001). Post-interventional GS values were 24.1 (SD 10.1), 26.2 (SD10.6) and 25.7 (SD 9.4) kg and TUG test values were 11.5 (SD 2.6), 12.0 (SD 3.7) and 11.9 (SD 3.2) s for 12,000 IU, 24,000 IU and 48,000 IU dose groups, respectively. The change (Δ) in GS and TUG from pre to post-intervention was not different between treatment groups before and after the adjustment for confounders, suggesting no effect of the intervention. Plasma 25OHD concentration was not associated with GS and TUG test after supplementation. In conclusion, plasma 25OHD concentration < 25 nmol/L was associated with lower GS at baseline. However, monthly vitamin D3 supplementation with 12,000 IU, 24,000 IU and 48,000 IU, for 12 months had no effect on muscle function in older adults aged 70+ years. Trial Registration : EudraCT 2011-004890-10 and ISRCTN35648481.

A reassessment of the vitamin D requirements of modern broiler genotypes.

We hypothesized that performance and bone mineralization of 2 broiler lines will benefit from increasing vitamin D (vitD) supplementation above current commercial levels and by partial substitution of D3 by 25-OH-D3. Male Ross 308 and 708 chicks (n = 576), were offered diets with low (LD; 1,000), medium (MD; 4,000) or high levels of D3 (HD; 7,000 IU/kg), and medium levels of vitD where the majority of D3 was substituted by 25-OH-D3 (25MD; 1,000 D3+3,000 25-OH-D3 IU/kg). Performance was measured at the end of starter (day 10), grower (day 24), and finisher periods (day 38). Three birds per pen were dissected at the end of each period to assess tibia and femur ash percentage (%), ash weight, bone breaking strength (BBS), and serum levels of 25-OH-D3. Remaining birds were gait scored (GS) at day 37 of age. Genotype and diet did not interact for any trait, whilst performance was not affected by diet. Ross 708 had lower body weight (P < 0.005), higher feed conversion ratio over the grower period (P < 0.05), similar levels of 25-OH-D3, but higher GS (P < 0.05) than Ross 308. Serum 25-OH-D3 levels were affected by diet at the end of the starter and grower periods (P < 0.05), being lowest for LD and highest for 25MD. Diet affected GS (P < 0.01), being higher in LD than 25MD. Femur ash % was higher at the end of the starter and grower periods for 25MD than LD and for both HD and 25MD than LD (P < 0.05). Femur and tibia ash weight were higher for 25MD in comparison to LD birds (P < 0.05) at the end of the grower period. Femur and tibia BBS were higher (P < 0.05) for 25MD in comparison to LD at the end of the grower and finisher periods, respectively. Overall, effects of vitD supply were more pronounced for femur than for tibia mineralization. Results do not suggest supplementation of vitD above current maximum levels and support partial substitution by 25-OH-D3.

Short communication: Effect of replacing corn with beet pulp in a high concentrate diet fed to weaned Holstein calves on diet digestibility and growth.

Using soluble fiber sources in starter and grower feeds for dairy calves less than 4 mo of age is common to reduce costs compared with including traditional cereal grains. Beet pulp (BP) contains relatively high concentrations of pectin compared with other fibrous feed ingredients and has been shown to be an acceptable replacement for corn in adult cow diets. However, limited information is available on BP digestibility and growth performance for young calves fed diets with BP. In this study, 48 male Holstein calves (59 ± 2 d of age, 77 ± 2.2 kg of initial body weight) were fed 95% concentrate, 5% chopped grass hay diets in groups with 4 calves/pen for 56 d. Pens were randomly assigned to 1 of 3 dietary treatments containing 0, 15, or 30% BP on an as-fed basis. Body weights, hip widths, and body condition scores were assessed at 56 (start of trial), 84, and 112 d of age. Dry matter intakes and refusals were recorded daily by pen. Digestion coefficients (dC) of the diets and microbial protein flows were estimated when calves were approximately 84 d of age. Fecal samples were collected daily from pen floors over a 7-d period, and urine samples were collected from 2 calves/pen over a 2-d period and analyzed for purine derivatives. Calf average daily gain and hip width change decreased linearly (from 1.09 to 1.04 kg/d and 5.4 to 4.8 cm over 56 d, respectively) with increasing BP. Dry matter, organic matter (from 79.7 to 75.6%), crude protein (75.7 to 70.1%), and starch (97.1 to 93.1%) dC decreased with increasing inclusion rates of BP. Conversely, neutral detergent fiber (from 47.1 to 52.7%) and acid detergent fiber (44.1 to 53.0%) dC increased with increasing BP. Estimates of urine output and microbial protein flow using purine derivatives did not differ among treatments. Under the conditions of this study, BP reduced growth largely by reducing diet digestibility in dairy calves from 56 to 112 d of age.

A 100-Year Review: Calf nutrition and management.

The first calf paper, published in the May 1919 issue of the Journal of Dairy Science (JDS), described factors affecting birth body weight of different breeds of calves. Other studies were done on nonmilk ingredients, growth charts were developed, and early weaning was followed to conserve milk fed to calves. Calf papers did not report use of statistics to control or record variation or to determine whether treatment means were different. Many experiments were more observational than comparative. Typically fewer than 5 calves, and sometimes 1 or 2 calves, were used per treatment. During the next 20 yr, calf studies increased and included colostrum feeding, milk and milk replacer feeding, minerals and vitamins, and fats and oils. Many concepts fundamental to current knowledge and understanding of digestion, rumen development, and milk replacer formulation were developed during this period. In addition, the concept of using antibiotic growth promoters in dairy calf diets was first evaluated and developed during the 1950s. During the 20-yr period of January 1957 through December 1976, a large number of universities in the United States and 1 in Canada contributed almost 150 papers on a variety of calf-related topics. These topics included genetics, physiology of the calf, review of calf immunity, antibiotic feeding, and milk replacer ingredients. This became the golden era of calf rumen development studies, which also engendered studies of calf starter rations and ingredients. A classic review of management, feeding, and housing studies summarized research related to calf feeding and management systems up to that point with an emphasis on maintaining calf growth and health while reducing labor and feed costs. It was also during this period that metric measurements replaced English units. In the 20-yr period from 1977 to 1996, more than 400 articles on calf nutrition and management were published in JDS. With the growing research interest in calves, a paper outlining standardized procedures for conducting and reporting data from calf experiments was first published. A very active area of calf nutrition research from the late 1970s to the mid 1980s was colostrum quality, feeding, and preservation; more than 60 such research articles were published in the journal during this time. Various nonmilk protein sources were evaluated. Extensive studies were done evaluating trace and major mineral requirements in calves along with some vitamin studies. Throughout the 1970s, 1980s, and 1990s, the primary objective of most calf research was how to wean healthy, adequately grown calves at an early age-generally less than 30 d of age. This program was reviewed in a 1979 publication. Research on calf starter ingredients, nutrient composition, and additives was minimal in the 1980s and 1990s given the importance of starter intake to the success of early weaning, but the role of water intake in starter intake and growth was established. Research on issues with calves continued to increase during the last 20-yr period as evidenced by publication of more than 580 articles in JDS as well as many more in other refereed journals. In addition to papers contributed by several universities in the United States and Canada, the number of papers authored by scientists at universities and institutes in other countries increased dramatically during this period. Factors influencing colostral antibody absorption, heat treatment of colostrum, and efficacy of colostrum supplements and replacers were reported. Most studies in this period related to nutrition. Studies were published supporting greater neonatal growth rates from feeding more milk replacer but with a higher crude protein content than traditional. Protein energy effects on growth and body composition were evaluated in concert with greater growth rates. Milk and nonmilk protein sources in milk replacers along with AA supplementation were evaluated. Limited studies were done with fat sources and fatty acid supplementation along with trace minerals and fat-soluble vitamins. Waste milk feeding and heat treatment became more prevalent. Studies established starter ingredient palatability and use of forage when fed with pelleted starters. With the advent of automatic milk and milk replacer feeders, factors influencing how and when to wean were established. Research programs established factors affecting calf behavior and welfare. Several databases were evaluated along with various published studies, and established calf growth during the first 2 mo was subsequently reflected in first- and later-lactation milk production of those calves. A new area of calf research that emerged from 1997 on was the effects of maternal environment and nutrition on calf health, growth, and future productivity. From a mechanistic standpoint, the field of epigenetics seems likely to explain many of these phenomena. Some possibilities for future calf nutrition and management were elaborated.

Effects of amount of colostrum replacer, amount of milk replacer, and housing cleanliness on health, growth, and intake of Holstein calves to 8 weeks of age.

Newborn Holstein bull calves (n = 96) were assigned randomly at birth to receive 150 g (C150) or 450 g (C450) of IgG in the first 24 h of life from a lacteal-based colostrum replacer in 2 trials. Mass of product fed was 500 and 1,500 g, respectively. Replacer was reconstituted with warm water and administered by esophageal feeder at approximately 1, 6, and 12 h of age. Thereafter, calves were fed 2 L of whole milk twice daily at approximately 0700 and 1700 h until transported to the experimental facility at 2 to 3 d of age. Calves fed C450 had greater serum total protein and IgG concentrations at 2 to 3 d of age. Failure of passive transfer of immunity (serum IgG <10 g/L) was detected in 100 and 11% of calves fed C150 and C450, respectively. Calves (n = 48) in trial 1 were assigned randomly within colostrum group to receive 0.68 kg/d of milk replacer (MR) for 42 d, and then 0.34 kg/d for 7 d (moderate MR, MMR) or 1 kg/d of MR for 5 d, 1.36 kg/d for 37 d, and 0.68 kg/d for 7 d (high MR, HMR). Starter and water were available for ad libitum consumption. Calves fed HMR had greater average daily gain, higher average fecal scores, more days with abnormal fecal scores, and more medical days than calves fed MMR. Calves fed HMR also had lower starter intake and tended to have lower gain-to-feed ratio than calves fed MMR. Calves fed C450 and MMR began eating calf starter earlier and ate more starter than other groups from 3 wk. In trial 2, calves (n = 48) were assigned randomly within colostrum group to housing in nursery pens bedded with clean, dry straw (clean bedding) or soiled straw used in previous studies (dirty bedding). Milk replacer was fed at 0.68 kg/d for 39 d, and then 0.34 kg/d for 3 d along with free-choice texturized starter and water. Calves fed C450 had fewer days with abnormal fecal scores and days with medical treatments compared with calves fed C150. Calves housed in dirty bedding tended to grow more slowly and have lower gain-to-feed ratio than calves housed with clean bedding. Temporal changes in serum IgG and total protein varied by treatment. Serum IgG in calves fed C150 varied little from 0 to 4 wk and increased thereafter, whereas IgG in calves fed C450 declined to 4 wk (estimated half-life = 23.9 d) and increased thereafter. Differences in serum IgG concentrations caused by feeding different amounts of colostrum replacer did not markedly affect growth or intake when calves were fed different amounts of milk replacer or when they were housed with clean or dirty bedding.

Source of carbohydrate and metabolizable lysine and methionine in the diet of recently weaned dairy calves on digestion and growth.

Two 56-d trials with weaned Holstein dairy calves (initially 72 ± 1.8 kg of body weight, 58 to 60 d of age) fed 95% concentrate and 5% chopped grass hay diets were conducted. Each trial used 96 calves (4 calves/pen). During 15 of the last 21 d of the first trial and 10 of 14 d of the second and third week of the second trial, fecal samples were taken to estimate digestibility using acid-insoluble ash as an internal marker. Digestibility estimates along with 56-d average daily gain (ADG), hip width change, body condition score, and fecal score were analyzed with pen as the experimental unit. In trial 1, a textured diet (19% crude protein) with high starch [52% starch, 13% neutral detergent fiber (NDF)] based on whole corn and oats or a pelleted low-starch (20% starch, 35% NDF), high-digestible fiber diet were used. Within starch level, diets were formulated from supplemental soybean meal or soybean meal with blood meal and Alimet (Novus International Inc., St. Charles, MO) to provide 2 metabolizable protein levels (1 and 1.07% metabolizable lysine plus methionine). The 4 treatments were analyzed as a completely randomized design with a 2 by 2 factorial arrangement (6 pens/diet). In trial 2, all pelleted diets (19% crude protein) were fed. Diets were based on soybean hulls, wheat middlings, or corn, which contained increasing concentrations of starch (13, 27, and 42% starch and 42, 23, and 16% NDF, respectively; 8 pens/diet). Contrast statements were constructed to separate differences in the means (soybean hulls plus wheat middlings vs. corn; soybean hulls vs. wheat middlings). In trial 1, intake of organic matter (OM) did not differ. Digestibility of OM was greater in calves fed high- versus low starch-diets. Digestibility of NDF and starch were less in calves fed the high- versus low-starch diets. Calf ADG and hip width change were greater for high- versus low-starch diets. Source of protein did not influence digestibility or ADG. In trial 2, intake of OM was not different. Digestibility of OM was greater in calves fed corn versus other diets. Digestibility of NDF was greater for calves fed soybean hulls versus wheat middlings. Starch digestibility was not different among treatments. Calf ADG and hip width change were greater in calves fed corn versus other diets. High-starch diets were more digestible and supported more growth in 2- to 4-mo-old dairy calves than replacing starch with digestible fiber. Manipulating metabolizable protein compared with a control diet that was predominately corn and soybean meal did not alter growth or digestibility.

Serum 25-hydroxyvitamin D concentration and its determinants in the very old: the Newcastle 85+ Study.

SUMMARY: Data on vitamin D status in very old adults are lacking. The aim of this study was to assess 25-hydroxyvitamin D [25(OH)D] concentrations and its predictors in 775 adults aged 85 years old living in North-East England. Low 25(OH)D was alarmingly high during winter/spring months, but its biological significance is unknown. INTRODUCTION: Despite recent concerns about the high prevalence of vitamin D deficiency in much of the British adult and paediatric population, there is a dearth of data on vitamin D status and its predictors in very old adults. The objective of the present study was to describe vitamin D status and its associated factors in a broadly representative sample of very old men and women aged 85 years living in the North East of England (55° N). METHODS: Serum concentrations of 25-hydroxyvitamin D [25(OH)D] were analysed in 775 participants in the baseline phase of the Newcastle 85+ cohort study. Season of blood sampling, dietary, health, lifestyle and anthropometric data were collected and included as potential predictors of vitamin D status in ordinal regression models. RESULTS: Median serum 25(OH)D concentrations were 27, 45, 43 and 33 nmol/L during spring, summer, autumn and winter, respectively. The prevalence of vitamin D deficiency according to North American Institute of Medicine guidelines [serum 25(OH)D <30 nmol/L] varied significantly with season with the highest prevalence observed in spring (51%) and the lowest prevalence observed in autumn (23%; P < 0.001). Reported median (inter-quartile range) dietary intakes of vitamin D were very low at 2.9 (1.2-3.3) µg/day. In multivariate ordinal regression models, non-users of either prescribed or non-prescribed vitamin D preparations and winter and spring blood sampling were associated with lower 25(OH)D concentrations. Dietary vitamin D intake, disability score and disease count were not independently associated with vitamin D status in the cohort. CONCLUSION: There is an alarming high prevalence of vitamin D deficiency (<30 nmol/L) in 85-year-olds living in North East England at all times of the year but particularly during winter and spring. Use of vitamin D containing preparations (both supplements and medications) appeared to be the strongest predictor of 25(OH)D concentrations in these very old adults.

Inclusion of tallow and soybean oil to calf starters fed to dairy calves from birth to four months of age on calf performance and digestion.

Energy demands for calves can increase during periods of heat and cold stress. One way to potentially increase energy intake is to increase the energy density of the feed with fat. Trial 1a compared a control starter with no added fat or oil (CON) to starters with 2% tallow (TAL) and 2% soybean oil (SBO). Starters were 20% crude protein (CP) and 45 to 47% starch. Male Holstein calves that were initially 3 to 5d of age were fed a 27% CP, 17% fat milk replacer at 0.66kg of dry matter daily and fully weaned by 42d of a 56-d trial. Trial 1b estimated the digestion of the diets (employed chromic oxide as an indigestible digesta flow marker) using a subset of 5 weaned calves per treatment between d 52 and 56. Trial 2 used Holstein calves initially 59 to 61d of age fed starters CON and SBO blended with 5% chopped grass hay over a 56-d trial. Trial 3 used Holstein calves initially 59 to 61d of age fed starters CON and TAL blended with 5% chopped grass hay over a 56-d trial. Treatments were compared using repeated measures (where appropriate) in a completely randomized design. In trials 1a and 1b, preplanned contrasts compared CON versus TAL and CON versus SBO. Compared with CON, calves fed SBO had reduced starter intake, average daily gain, and digestion of dry matter, organic matter, and CP before 8wk of age. Compared with CON, calves fed SBO had reduced average daily gain and change in hip width from 2 to 4 mo of age. Compared with CON, calves fed TAL had reduced average daily gain and tended to have reduced change in hip width from 2 to 4 mo of age. Calculated metabolizable energy intake was not increased in any trial by added fat or oil. Tallow and soybean oil inclusion at 2% of the starter feed was not advantageous for calf growth before 4 mo of age.

Serum 25-hydroxyvitamin D and cognitive decline in the very old: the Newcastle 85+ Study.

BACKGROUND AND PURPOSE: Studies investigating the association between 25-hydroxyvitamin D [25(OH)D] and cognition in the very old (85+) are lacking. METHODS: Cross-sectional (baseline) and prospective data (up to 3 years follow-up) from 775 participants in the Newcastle 85+ Study were analysed for global (measured by the Standardized Mini-Mental State Examination) and attention-specific (measured by the attention battery of the Cognitive Drug Research test) cognitive performance in relation to season-specific 25(OH)D quartiles. RESULTS: Those in the lowest and highest season-specific 25(OH)D quartiles had an increased risk of impaired prevalent (1.66, 95% confidence interval 1.06-2.60, P = 0.03; 1.62, 95% confidence interval 1.02-2.59, P = 0.04, respectively) but not incident global cognitive functioning or decline in functioning compared with those in the middle quartiles adjusted for sociodemographic, health and lifestyle confounders. Random effects models showed that participants belonging to the lowest and highest 25(OH)D quartiles, compared with those in the middle quartiles, had overall slower (log-transformed) attention reaction times for Choice Reaction Time (lowest, ß = 0.023, P = 0.01; highest, ß = 0.021, P = 0.02), Digit Vigilance Task (lowest, ß = 0.009, P = 0.05; highest, ß = 0.01, P = 0.02) and Power of Attention (lowest, ß = 0.017, P = 0.02; highest, ß = 0.022, P = 0.002) and greater Reaction Time Variability (lowest, ß = 0.021, P = 0.02; highest, ß = 0.02, P = 0.03). The increased risk of worse global cognition and attention amongst those in the highest quartile was not observed in non-users of vitamin D supplements/medication. CONCLUSION: Low and high season-specific 25(OH)D quartiles were associated with prevalent cognitive impairment and poorer overall performance in attention-specific tasks over 3 years in the very old, but not with global cognitive decline or incident impairment.

25-hydroxyvitamin D and increased all-cause mortality in very old women: the Newcastle 85+ study.

OBJECTIVE: To investigate the associations between low and high concentrations of baseline serum 25-hydroxyvitamin D [25(OH)D] and all-cause mortality in very old (≥85 years) men and women over 6 years. DESIGN, SETTING AND SUBJECTS: Prospective mortality data from 775 participants in the Newcastle 85+ Study were analysed for survival in relation to 25(OH)D (season-specific quartiles and predefined cut-off values) and sex using Cox proportional hazards models. The models were fitted to the entire and restricted (nonusers of vitamin D-containing supplements and medication) cohorts. RESULTS: For the entire cohort, mortality was higher in both the lowest and highest 25(OH)D season-specific quartiles [SQ1: hazard ratio (HR) 1.31, 95% confidence interval (CI) 1.01-1.69, P = 0.04; SQ4: HR 1.44, 95% CI 1.12-1.85, P = 0.004] compared with the combined middle quartiles (SQ2 + SQ3), after adjustment for sociodemographic factors. The increased risk for the highest quartile remained significant after further adjustment for lifestyle variables (SQ4: HR 1.37, 95% CI 1.06-1.77, P = 0.02) and was seen only in women in sex-specific analyses. Similarly, in sensitivity analyses with predefined 25(OH)D cut-off values, the highest 25(OH)D concentration (≥75 nmol L(-1) ) was associated with a 2.4-fold increased risk of mortality in women (restricted cohort) after adjusting for all covariates. CONCLUSION: Low and high season-specific 25(OH)D quartiles were associated with increased risks of mortality over 6 years in the very old; this effect was particularly noticeable in women, including those who reported taking vitamin D-containing supplements/medication.

Comparison of supplementation of n-3 fatty acids from fish and flax oil on cytokine gene expression and growth of milk-fed Holstein calves.

The ability to reduce incidence of disease in calves and improve early vaccination strategies is of particular interest for dairy producers. The n-3 fatty acids have been reported to reduce inflammatory diseases in humans but limited research has been done in calves. The objective of this study was to compare supplementation of n-3 fatty acids from fish and flax oil on gene expression of whole blood cells and growth of milk-fed Holstein calves. Forty-eight Holstein bull calves from a commercial dairy were randomly assigned to 1 of 3 diets beginning at 4d old: (1) control milk replacer (MR) with all pork fat, (2) MR with 2% flax oil, and (3) MR with 2% fish oil. All MR were 17% fat, 27% crude protein on a dry matter (DM) basis, with all protein from whey sources. Calves were each fed 654g DM of MR daily for the first 25d and then 327g/d for d26, 27, and 28. On d28, calves were challenged with a Pasteurella vaccine and the temperature response to the vaccine was recorded. Milk and feed intake and fecal scores were recorded daily, and body weight and hip width were recorded weekly. Blood was collected from all calves on d25. One tube of collected blood was incubated with endotoxin (lipopolysaccharide; LPS) for 2h and frozen with a second tube of control blood. Quantitative real-time PCR was used to assess the effects of LPS stimulation on cytokine gene expression. During the 28 d, calves supplemented with flax oil had a greater growth rate and feed efficiency than calves fed fish oil (0.52±0.02 vs. 0.48±0.02g of gain:g of feed). Fish oil tended to decrease LPS stimulation of tumor necrosis factor-α expression. Flax oil, but not fish oil, decreased the expression of IL-4 and tended to decrease expression of osteopontin and IL-8. Flax oil tended to reduce the increase in rectal temperature in response to a Pasteurella vaccine. In conclusion, our data support the idea that supplementation with n-3 fatty acids affects cytokine gene expression.

Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.

BACKGROUND AND PURPOSE: Epilepsy is the most prevalent neurological disease and is characterized by recurrent seizures. Here, we investigate (i) the anticonvulsant profiles of cannabis-derived botanical drug substances (BDSs) rich in cannabidivarin (CBDV) and containing cannabidiol (CBD) in acute in vivo seizure models and (ii) the binding of CBDV BDSs and their components at cannabinoid CB1 receptors. EXPERIMENTAL APPROACH: The anticonvulsant profiles of two CBDV BDSs (50-422 mg·kg(-1) ) were evaluated in three animal models of acute seizure. Purified CBDV and CBD were also evaluated in an isobolographic study to evaluate potential pharmacological interactions. CBDV BDS effects on motor function were also investigated using static beam and grip strength assays. Binding of CBDV BDSs to cannabinoid CB1 receptors was evaluated using displacement binding assays. KEY RESULTS: CBDV BDSs exerted significant anticonvulsant effects in the pentylenetetrazole (≥100 mg·kg(-1) ) and audiogenic seizure models (≥87 mg·kg(-1) ), and suppressed pilocarpine-induced convulsions (≥100 mg·kg(-1) ). The isobolographic study revealed that the anticonvulsant effects of purified CBDV and CBD were linearly additive when co-administered. Some motor effects of CBDV BDSs were observed on static beam performance; no effects on grip strength were found. The Δ(9) -tetrahydrocannabinol and Δ(9) -tetrahydrocannabivarin content of CBDV BDS accounted for its greater affinity for CB1 cannabinoid receptors than purified CBDV. CONCLUSIONS AND IMPLICATIONS: CBDV BDSs exerted significant anticonvulsant effects in three models of seizure that were not mediated by the CB1 cannabinoid receptor and were of comparable efficacy with purified CBDV. These findings strongly support the further clinical development of CBDV BDSs for the treatment of epilepsy.

Intake of specific fatty acids and fat alters growth, health, and titers following vaccination in dairy calves.

Typical fatty acid profiles of milk and milk replacer (MR) differ. Calf MR in the United States are made from animal fat, which are low in short- and medium-chain fatty acids and linolenic acid. Two 56-d trials compared a control MR containing 27% crude protein and formulated with 3 fat and fatty acid compositions. The 3 MR treatments were (1) only animal fat totaling 17% fat (CON), (2) animal fat supplemented with butyrate, medium-chain fatty acids, and linolenic acid using a commercial product (1.25% NeoTec4 MR; Provimi North America, Brookville, OH) totaling 17% fat (fatty acid-supplemented; FA-S), and (3) milk fat totaling 33% fat (MF). The MR were fed at 660 g of dry matter from d 0 to 42 and weaned. Starter (20% crude protein) and water were fed ad libitum for 56 d. Trial 1 utilized Holstein calves (24 female, 24 male) during summer months and trial 2 utilized Holstein calves (48 male) during fall months. Calves (41±1 kg of initial body weight; 2 to 3d of age) were sourced from a single farm and housed in a naturally ventilated nursery without added heat. Calves were in individual pens with straw bedding. Calf was the experimental unit. Data for each trial were analyzed as a completely randomized design with a 3 (MR treatment) × 2 (sex) factorial arrangement of treatments in trial 1 with repeated measures and as a completely randomized design with 3 MR treatments in trial 2 with repeated measures. Preplanned contrast statements of treatments CON versus FA-S and CON versus MF were used to separate means. We found no interactions of MR treatment by sex. Calf average daily gain, hip width change, and feed efficiency differed (CONFA-S). Titers to bovine respiratory parainfluenza-3 and bovine virus diarrhea type 1 (vaccinations to these pathogens were on d 7 and 28) in serum samples taken on d 49 and 56 differed (CONFA-S; CONFA-S; CON>MF). Calves fed FA-S and MF had improved growth and feed efficiency compared with calves fed CON, whereas calves fed FA-S also had improved measurements related to health and immunity.

Cannabidivarin is anticonvulsant in mouse and rat.

BACKGROUND AND PURPOSE: Phytocannabinoids in Cannabis sativa have diverse pharmacological targets extending beyond cannabinoid receptors and several exert notable anticonvulsant effects. For the first time, we investigated the anticonvulsant profile of the phytocannabinoid cannabidivarin (CBDV) in vitro and in in vivo seizure models. EXPERIMENTAL APPROACH: The effect of CBDV (1-100 µM) on epileptiform local field potentials (LFPs) induced in rat hippocampal brain slices by 4-aminopyridine (4-AP) application or Mg(2+) -free conditions was assessed by in vitro multi-electrode array recordings. Additionally, the anticonvulsant profile of CBDV (50-200 mg·kg(-1) ) in vivo was investigated in four rodent seizure models: maximal electroshock (mES) and audiogenic seizures in mice, and pentylenetetrazole (PTZ) and pilocarpine-induced seizures in rats. The effects of CBDV in combination with commonly used antiepileptic drugs on rat seizures were investigated. Finally, the motor side effect profile of CBDV was investigated using static beam and grip strength assays. KEY RESULTS: CBDV significantly attenuated status epilepticus-like epileptiform LFPs induced by 4-AP and Mg(2+) -free conditions. CBDV had significant anticonvulsant effects on the mES (≥100 mg·kg(-1) ), audiogenic (≥50 mg·kg(-1) ) and PTZ-induced seizures (≥100 mg·kg(-1) ). CBDV (200 mg·kg(-1) ) alone had no effect against pilocarpine-induced seizures, but significantly attenuated these seizures when administered with valproate or phenobarbital at this dose. CBDV had no effect on motor function. CONCLUSIONS AND IMPLICATIONS: These results indicate that CBDV is an effective anticonvulsant in a broad range of seizure models. Also it did not significantly affect normal motor function and, therefore, merits further investigation as a novel anti-epileptic in chronic epilepsy models. LINKED ARTICLES: This article is part of a themed section on Cannabinoids. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.167.issue-8.

Fatty acid intake alters growth and immunity in milk-fed calves.

The aim of the present study was to determine the effect of supplementing milk replacer (MR) with NeoTec4 (Provimi North America, Brookville, OH), a commercially available blend of butyric acid, coconut oil, and flax oil, on calf growth, efficiency, and indices of immune function. In trial 1a, 48 male Holstein calves were fed either a control MR that contained only animal fat or the same MR with NeoTec4 (treatment) along with free-choice starter. The MR (28.7% crude protein, 15.6% fat) was fed at an average of 1 kg of dry matter (DM)/d. In trial 1b, weaned calves from trial 1a were all fed dry starter for 28 d without NeoTec4 (phase 1), and then half the calves were fed NeoTec4 for 28 d (phase 2). In trial 2, 40 male Holstein calves were fed a control MR with lard, coconut oil, and soy lecithin or the same MR supplemented with NeoTec4 (treatment). The MR (22.8% crude protein, 18.9% fat) was fed at an average of 1 kg of DM/d; no starter was fed. In trial 1a, NeoTec4 improved average daily gain, feed intake, and feed efficiency, reduced the number of days that calves experienced scours, and reduced the medical treatments for clostridium sickness. In trials 1a and 2, NeoTec4 altered the inflammatory response to vaccination with Pasteurella at 5 wk of age and to challenge with Salmonella toxin at less than 2 wk of age (fed NeoTec4 for 6 d), as observed by reduced hyperthermia and hypophagia, and altered the tumor necrosis factor-α response. In addition, NeoTec4 enhanced the response in IL-4 and globular protein estimates postchallenge and enhanced titers for bovine viral diarrhea and respiratory parainfluenza-3. Postchallenge serum concentrations of albumin were lower and urea nitrogen concentrations were greater in control calves than in calves fed NeoTec4. In trial 1b, performance did not differ during the first 28 d when no calves received NeoTec4, but calves receiving NeoTec4 in the second 28 d had greater average daily gain and feed efficiency. We conclude that supplementation of MR with NeoTec4 alters some immune and inflammatory responses, including increasing titers to bovine viral diarrhea and respiratory parainfluenza-3 vaccinations, reduces scours, reduces medical treatments for clostridium sickness, and improves growth rates and feed efficiency.

Effects of fat concentration of a high-protein milk replacer on calf performance.

The hypothesis was that calves fed high-fat milk replacers (MR) would have reduced starter intake, digestibility, and average daily gain (ADG). Forty-eight Holstein calves (initially 42.4 +/- 1.5 kg of body weight, 2 to 3 d of age; 12 calves/treatment) were fed 0.66 kg dry matter (DM) of MR per calf daily that contained 14, 17, 20, or 23% fat. This MR had crude protein (CP) to metabolizable energy (ME) ratios ranging from 51.6 to 56.7 g of CP/Mcal of ME, which were above and below a previously determined optimum. Calves were weaned at 28 d; postweaning measurements were continued to d 56. A 20% CP starter and water were fed ad libitum all 56 d of the trial. Measurements of digestion were made using chromic oxide as a marker in the MR and starter from fecal samples collected on d 19 to 23 from 4 calves/treatment. Selected serum constituents were measured on d 21. Calves were housed individually in pens bedded with straw within a naturally ventilated barn with no added heat. The average barn temperature was 2 degrees C. Data were analyzed as a completely randomized design using polynomial contrasts to separate differences in the means. Preweaning apparent digestibility of DM, organic matter, fat, nonfiber carbohydrates, Ca, and P and serum amylase concentration were linearly reduced as fat increased from 14 to 23%. Preweaning starter intake responded quadratically to fat, being lowest at 14 and 23% fat. A reduction in digestibility and starter intake contributed to less ADG at the higher fat concentrations in the MR. A 27% CP, 17% fat MR with 55 g of CP/Mcal of ME maximized preweaning ADG when fat concentration was varied to obtain various CP to ME ratios in the MR. Additionally, a 27% CP, 20% fat MR with 53 g of CP/Mcal of ME supported overall ADG similar to calves fed the 17% fat MR but preweaning digestion measurements and serum amylase concentrations were less than in calves fed the 17% fat MR.